首页 | 本学科首页   官方微博 | 高级检索  
     


Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
Authors:Mari Bunkholt Elstrand,Hiep Phuc Dong,Elin Ø  degaard,Arild Holth,Sivan Elloul,Reuven Reich,Claes G. Tropé  ,Ben Davidson
Affiliation:a Division of Obstetrics and Gynecology, Section for Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
b Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
c Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
d Faculty Division Radiumhospitalet, the Medical Faculty, University of Oslo, N-0316 Oslo, Norway
Abstract:
Keywords:AKT   mTOR   DJ-1   Serous ovarian carcinoma   Effusions   Survival
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号